Result Summary for COL30574
| Protocol ID: | COL30574 |
| Clinical Study ID: | COL30574 |
| Official Title: | A phase IIIB, non-comparative, single arm, open-label, multicenter study on antiviral efficacy and safety of the approach “Induction- Maintenance” in patients with HIV-1 infection naïve to antiretroviral therapy. A 72-week study on the scheme: induction with TRIZIVIR® + SUSTIVA® or COMBIVIR® + SUSTIVA® OR COM |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | abacavir/lamivudine/zidovudine |
| Trade/Product Name: | Ziagen,ZIAGENAVIR |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
